These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1661058)

  • 41. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
    Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
    Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems.
    Ohtake T; Abe R; Kimijima I; Fukushima T; Tsuchiya A; Hoshi K; Wakasa H
    Cancer; 1995 Jul; 76(1):32-45. PubMed ID: 8630874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Procedures of analytic morphometry in the monitoring of nuclear changes of breast ductal epithelium from normal to carcinoma].
    Giardina C; Serio G; Potente F; Pennella A; Lettini T; Di Tolve P; Ricco R; Pesce Delfino V
    Pathologica; 1992; 84(1094):97-100. PubMed ID: 1338654
    [No Abstract]   [Full Text] [Related]  

  • 44. AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast.
    Guski H; Hufnagl P; Kaufmann O; Krause M; Winzer KJ
    Anal Quant Cytol Histol; 2000 Jun; 22(3):206-12. PubMed ID: 10872036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Relevance of palpatory, mammographic and thermographic assessment criteria in benign and malignant structural changes in the female breast].
    Bartl W; Pfersmann C; Schlögl H; Dadak C
    Wien Klin Wochenschr; 1986 Dec; 98(23):797-803. PubMed ID: 3027995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphometric Analysis in the Diagnosis of Low-Grade Ductal and Lobular Carcinoma in Situ of the Breast.
    Parra-Herran C; Hope T; Rashed T; Slodkowska E; Lu FI; Nofech-Mozes S
    Anal Quant Cytopathol Histpathol; 2015 Dec; 37(6):331-8. PubMed ID: 26860008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
    Moriya T; Silverberg SG
    Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
    Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The breast stem cell (CK5/6(+)) concept and its relation to the diagnosis of benign and malignant ductal epithelial hyperplasia].
    Huang SF
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):73-7. PubMed ID: 23710910
    [No Abstract]   [Full Text] [Related]  

  • 51. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
    Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
    Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contextual analysis complements single-cell analysis in the diagnosis of breast cancer in fine needle aspirates.
    Detweiler R; Zahniser DJ; Garcia GL; Hutchinson M
    Anal Quant Cytol Histol; 1988 Feb; 10(1):10-5. PubMed ID: 2833288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy.
    Hou Y; Chaudhary S; Gao FF; Li Z
    Ann Diagn Pathol; 2016 Oct; 24():4-6. PubMed ID: 27649945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Role of cytokeratin expression in differential diagnosis of intraductal proliferative lesions of breast].
    Zhang JL; Zhang HY; Wei B; Lang ZQ; Bu H
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):316-9. PubMed ID: 15363314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histological assessment of breast lesions identified exclusively by magnetic resonance.
    O'Connor V; Arena E; Albright J; Brown N; O'Connor R; Chung M; DiNome M; Shamonki J
    Am Surg; 2014 Oct; 80(10):944-7. PubMed ID: 25264635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors.
    Tse GM; Cheung HS; Pang LM; Chu WC; Law BK; Kung FY; Yeung DK
    AJR Am J Roentgenol; 2003 Nov; 181(5):1267-72. PubMed ID: 14573418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endoscopic and histologic findings of intraductal lesions presenting with nipple discharge.
    Makita M; Akiyama F; Gomi N; Iwase T; Kasumi F; Sakamoto G
    Breast J; 2006; 12(5 Suppl 2):S210-7. PubMed ID: 16959004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pseudoadenoid cystic carcinoma of the breast.
    Harris M
    Arch Pathol Lab Med; 1977 Jun; 101(6):307-9. PubMed ID: 193457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathological criteria and practical issues in papillary lesions of the breast - a review.
    Ni YB; Tse GM
    Histopathology; 2016 Jan; 68(1):22-32. PubMed ID: 26768027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.